Kenvue Inc.
NYSE:KVUEHousehold & Personal Products
+$0.18 today
- Market cap
- $37.09B
- Beta
- 0.50
- P/E (TTM)
- 21.5
- EPS (TTM)
- $0.85
- Dividend yield
- 4.56%
Volume 66.38M
Average 19.42M
KVUE Common Stock Repurchased
Cash spent buying back the company's own shares.
Kenvue Inc.NYSE: KVUE
Common Stock Repurchased · Q3 FY2026 · quarter ended Sep 2026
Common stock repurchased turns positive
Q3 FY2026 common stock repurchased was $0, compared with -$70M a year earlier. Trailing-twelve-month common stock repurchased was $0.
Context
- Common stock repurchased amounted to 1.3% of revenue in FY2025, down 0.2 pp from a year earlier.
- Common stock repurchased increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly common stock repurchased holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Repurchased history
USD · from the cash flow
- Latest · FY2025
- (197M) USD
- Year-over-year change
- +16.2%
| Period | Period end | Common Stock Repurchased | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-28 | (197M) | +16.2% |
| FY2024 | 2024-12-29 | (235M) | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Common Stock Repurchased vs competitors
How KVUE compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock repurchased is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +100.0% is the 2nd highest of 8, against a peer median of -13.5%.
- Common stock repurchased amounts to 0.0% of revenue for KVUE, versus a peer median of 5.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $5.03B USD | -13.5% | -11.9% | 5.7% | |
| FY2025 | €1.45B EUR | -3.8% | -1.3% | 2.9% | |
| LTM Sep 2026 | $1.33B USD | +5.9% | -2.6% | 6.3% | |
| FY2025 | £639.67M GBP | +428.7% | — | 5.8% | |
| LTM Sep 2026 | $337.1M USD | -43.8% | — | 5.4% | |
| LTM Sep 2026 | $137M USD | -13800.0% | -36.3% | 0.9% | |
| LTM Mar 2026 | $43.2M USD | -54.0% | -10.4% | 2.1% | |
| LTM Sep 2026 | $0 USD | +100.0% | — | 0.0% | |
| Peer median (excluding KVUE) | — | -13.5% | -10.4% | 5.4% | |
Competitors are the stored peer set for KVUE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.03B | 2.09B | 1.66B | 1.03B | 1.47B |
| Depreciation & Amortization | 731M | 644M | 627M | 622M | 557M |
| Deferred Income Tax | 568M | 157M | (114M) | (285M) | (108M) |
| Stock-Based Compensation | 141M | 137M | 188M | 254M | 136M |
| Change in Working Capital | (3.13B) | (513M) | 797M | (571M) | 52M |
| Accounts Receivables | (303M) | (142M) | 44M | (218M) | (112M) |
| Inventory | (77M) | (582M) | 349M | 182M | (12M) |
| Accounts Payables | 330M | 52M | 390M | (536M) | 41M |
| Other Working Capital | (3.08B) | 159M | 14M | 1M | 135M |
| Other Non-Cash Items | (5M) | 13M | 6M | 719M | 90M |
| Operating Cash Flow | 334M | 2.53B | 3.17B | 1.77B | 2.2B |
| Capital Expenditures | (295M) | (375M) | (469M) | (434M) | (475M) |
| Acquisitions (Net) | 136M | (10M) | 21M | 0 | 0 |
| Purchases of Investments | (12M) | (5M) | 0 | 0 | 0 |
| Sales of Investments | 77M | 8M | 0 | 0 | 0 |
| Other Investing Activities | (77M) | (8M) | (40M) | 9M | (435.5M) |
| Investing Cash Flow | (171M) | (390M) | (488M) | (425M) | (436M) |
| Debt Repayment | (7M) | 14M | 8.25B | 159M | (150M) |
| Common Stock Issued | 0 | 0 | 4.24B | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (235M) | (197M) |
| Dividends Paid | 0 | 0 | (14.55B) | (1.55B) | (1.58B) |
| Other Financing Activities | 7M | (1.6B) | (460M) | 63M | 91M |
| Financing Cash Flow | 0 | (1.58B) | (2.53B) | (1.57B) | (1.84B) |
| Effect of Forex Changes | (41M) | (61M) | (2M) | (91M) | 68M |
| Net Change in Cash | 122M | 491M | 151M | (312M) | (8M) |
| Free Cash Flow | 39M | 2.15B | 2.7B | 1.34B | 1.72B |
Kenvue Inc.
NYSE:KVUE
Intrinsic Alpha fair value
Locked
Current Price
$19.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.